These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 32958331)

  • 41. Opioids in pregnancy and neonatal abstinence syndrome.
    Stover MW; Davis JM
    Semin Perinatol; 2015 Nov; 39(7):561-5. PubMed ID: 26452318
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Maternal prepregnancy surgery and risk of neonatal abstinence syndrome in future newborns: a longitudinal cohort study.
    Auger N; Low N; Carrier FM; Ayoub A; Luu TM
    CMAJ; 2019 Jul; 191(28):E779-E786. PubMed ID: 31308006
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Neonatal abstinence syndrome: Historical perspective, current focus, future directions.
    Jones HE; Fielder A
    Prev Med; 2015 Nov; 80():12-7. PubMed ID: 26232620
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Opioid maintenance treatment during pregnancy: occurrence and severity of neonatal abstinence syndrome. A national prospective study.
    Bakstad B; Sarfi M; Welle-Strand GK; Ravndal E
    Eur Addict Res; 2009; 15(3):128-34. PubMed ID: 19332991
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cognitive and Motor Outcomes of Children With Prenatal Opioid Exposure: A Systematic Review and Meta-analysis.
    Yeoh SL; Eastwood J; Wright IM; Morton R; Melhuish E; Ward M; Oei JL
    JAMA Netw Open; 2019 Jul; 2(7):e197025. PubMed ID: 31298718
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Gestational buprenorphine exposure: Effects on pregnancy, development, neonatal opioid withdrawal syndrome, and behavior in a translational rodent model.
    Wallin CM; Bowen SE; Roberge CL; Richardson LM; Brummelte S
    Drug Alcohol Depend; 2019 Dec; 205():107625. PubMed ID: 31706250
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Visual and oculomotor outcomes in children with prenatal opioid exposure.
    Lambert JE; Peeler CE
    Curr Opin Ophthalmol; 2019 Nov; 30(6):449-453. PubMed ID: 31449086
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Brain morphology in school-aged children with prenatal opioid exposure: A structural MRI study.
    Sirnes E; Oltedal L; Bartsch H; Eide GE; Elgen IB; Aukland SM
    Early Hum Dev; 2017; 106-107():33-39. PubMed ID: 28187337
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prenatal opioid exposure is associated with smaller brain volumes in multiple regions.
    Merhar SL; Kline JE; Braimah A; Kline-Fath BM; Tkach JA; Altaye M; He L; Parikh NA
    Pediatr Res; 2021 Aug; 90(2):397-402. PubMed ID: 33177677
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Child neuroanatomical, neurocognitive, and visual acuity outcomes with maternal opioid and polysubstance detoxification.
    Walhovd KB; Bjørnebekk A; Haabrekke K; Siqveland T; Slinning K; Nygaard E; Fjell AM; Due-Tønnessen P; Bjørnerud A; Moe V
    Pediatr Neurol; 2015 Mar; 52(3):326-32.e1-3. PubMed ID: 25595574
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hospitalization of children after prenatal exposure to opioid maintenance therapy during pregnancy: a national registry study from the Czech Republic.
    Skurtveit S; Nechanská B; Handal M; Mahic M; Mravčík V; Gabrhelík R
    Addiction; 2019 Jul; 114(7):1225-1235. PubMed ID: 30725515
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prenatal opioid exposure by likelihood of exposure and risk to prenatal development: Medicaid-covered births in Wisconsin, 2010-2019.
    Berger LM; Durrance C; Ehrenthal D; Kim H; Kuo HH; Pac J
    Sci Adv; 2024 May; 10(19):eadg9674. PubMed ID: 38718116
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prenatal opioid exposure: The next neonatal neuroinflammatory disease.
    Jantzie LL; Maxwell JR; Newville JC; Yellowhair TR; Kitase Y; Madurai N; Ramachandra S; Bakhireva LN; Northington FJ; Gerner G; Tekes A; Milio LA; Brigman JL; Robinson S; Allan A
    Brain Behav Immun; 2020 Feb; 84():45-58. PubMed ID: 31765790
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Developmental Outcomes after Opioid Exposure in the Fetus and Neonate.
    Fong J; Lewis J; Lam M; Kesavan K
    Neoreviews; 2024 Jun; 25(6):e325-e337. PubMed ID: 38821910
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Are infants exposed to methadone in utero at an increased risk for mortality?
    Kelly LE; Rieder MJ; Bridgman-Acker K; Lauwers A; Madadi P; Koren G
    J Popul Ther Clin Pharmacol; 2012; 19(2):e160-5. PubMed ID: 22580362
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The relationship between gestational age and the severity of neonatal abstinence syndrome.
    Gibson KS; Stark S; Kumar D; Bailit JL
    Addiction; 2017 Apr; 112(4):711-716. PubMed ID: 27886650
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Systematic mixed-study review of nonpharmacological management of neonatal abstinence syndrome.
    MacVicar S; Kelly LE
    Birth; 2019 Sep; 46(3):428-438. PubMed ID: 30938466
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Childhood neurodevelopment after prescription of maintenance methadone for opioid dependency in pregnancy: a systematic review and meta-analysis.
    Monnelly VJ; Hamilton R; Chappell FM; Mactier H; Boardman JP
    Dev Med Child Neurol; 2019 Jul; 61(7):750-760. PubMed ID: 30511742
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Neonatal abstinence syndrome in methadone-exposed infants is altered by level of prenatal tobacco exposure.
    Choo RE; Huestis MA; Schroeder JR; Shin AS; Jones HE
    Drug Alcohol Depend; 2004 Sep; 75(3):253-60. PubMed ID: 15283946
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Neonatal abstinence syndrome and the gastrointestinal tract.
    Maguire D; Gröer M
    Med Hypotheses; 2016 Dec; 97():11-15. PubMed ID: 27876117
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.